当前位置:首页 - 行情中心 - 双鹭药业(002038) - 财务分析

双鹭药业

(002038)

  

流通市值:57.90亿  总市值:69.86亿
流通股本:8.52亿   总股本:10.27亿

双鹭药业(002038)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润0.46亿元,每股收益0.04元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益562626.54万元,未分配利润389556.54万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产606470.28万元,负债43843.74万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入168,896,131.59660,419,604.31540,562,431.05392,063,433.48
营业总成本155,955,363.45621,412,318.94461,951,501.39261,700,152.08
营业利润48,346,156.71-119,603,351.98-32,315,344.2418,484,775.93
利润总额48,023,120.94-133,749,652.64-37,166,807.1318,481,831.74
净利润45,617,183.33-75,286,762.98-17,745,874.2528,784,151.99
其他综合收益----
综合收益总额45,617,183.33-75,286,762.98-17,745,874.2528,784,151.99
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计2,561,788,777.042,488,838,965.652,204,724,372.872,415,088,082.81
非流动资产合计3,502,914,062.023,490,180,353.093,706,909,065.43,676,125,561.41
资产总计6,064,702,839.065,979,019,318.745,911,633,438.276,091,213,644.22
流动负债合计333,994,890.92289,405,120.31204,559,225.76178,473,302.22
非流动负债合计104,442,525.43108,965,959.0568,885,084.473,918,687.65
负债合计438,437,416.35398,371,079.36273,444,310.16252,391,989.87
归属于母公司股东权益合计5,618,416,348.025,572,447,942.45,629,778,019.035,830,206,101.47
股东权益合计5,626,265,422.715,580,648,239.385,638,189,128.115,838,821,654.35
负债和股东权益合计6,064,702,839.065,979,019,318.745,911,633,438.276,091,213,644.22
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计310,516,385.711,047,395,093.42647,132,663.44474,582,868.7
经营活动现金流出小计366,508,779.91821,907,910.31519,301,184.02338,777,654.31
经营活动产生的现金流量净额-55,992,394.2225,487,183.11127,831,479.42135,805,214.39
投资活动现金流入小计-484,619,399.51329,700,097.7875,828,259
投资活动现金流出小计131,848,452.89696,169,273.41419,921,793.54102,796,429.47
投资活动产生的现金流量净额-131,848,452.89-211,549,873.9-90,221,695.76-26,968,170.47
筹资活动现金流入小计----
筹资活动现金流出小计-154,102,500154,102,500-
筹资活动产生的现金流量净额--154,102,500-154,102,500-
汇率变动对现金及现金等价物的影响4.5-2-3.45-1.89
现金及现金等价物净增加额-187,840,842.59-140,165,192.79-116,492,719.79108,837,042.03
期末现金及现金等价物余额212,037,406.38399,878,248.97423,550,721.97648,880,483.79
TOP↑